Literature DB >> 1555843

Leiomyoma exhibiting a marked granular change: granular cell leiomyoma versus granular cell schwannoma.

T Shimokama1, T Watanabe.   

Abstract

Granular change of leiomyoma or granular cell leiomyoma is rare and not well recognized. It may be confused with the common variety of granular cell tumor, which is currently regarded as being of schwannian origin. A case of granular cell leiomyoma in the periurethral region of a 40-year-old woman is reported. Microscopy indicated that the tumor consisted of polygonal or fusiform cells with coarse, granular eosinophilic cytoplasm. Immunohistochemically, the tumor cells were positive for desmin and actin, but negative for neuron-specific enolase and S-100 protein. Electron microscopy revealed myofilaments in the tumor cells, thus documenting the myogenic origin of the granular cells. The granules were ultrastructurally similar to those of granular cell schwannoma as described in the literature. It is likely that granular cell tumor arises from different tissues.

Entities:  

Mesh:

Year:  1992        PMID: 1555843     DOI: 10.1016/0046-8177(92)90116-k

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Granular Cell Variant of Atypical Fibroxanthoma.

Authors:  Zsolt Orosz; János Kelemen; Zoltán Szentirmay
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Primitive Cutaneous (P)erivascular (E)pithelioid (C)ell Tumour (PEComa): A New Case Report of a Rare Cutaneous Tumor.

Authors:  Gerardo Cazzato; Anna Colagrande; Lucia Lospalluti; Lucia Pacello; Teresa Lettini; Francesca Arezzo; Vera Loizzi; Carmelo Lupo; Nadia Casatta; Gennaro Cormio; Eugenio Maiorano; Giuseppe Ingravallo; Leonardo Resta
Journal:  Genes (Basel)       Date:  2022-06-26       Impact factor: 4.141

3.  Nodular granular muscle degeneration of the appendix and obesity.

Authors:  A Handra-Luca
Journal:  J Postgrad Med       Date:  2015 Apr-Jun       Impact factor: 1.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.